Rejoinder: Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes

Documenti analoghi

• Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes
  di: Benkeser, David, et al.
  Pubblicazione: (2020)
• Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes
  di: Benkeser, David, et al.
  Pubblicazione: (2020)
• Discussion of “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes”
  di: Zhang, Min, et al.
  Pubblicazione: (2021)
• Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment for binary, ordinal, and time‐to‐event outcomes”
  di: Proschan, Michael A.
  Pubblicazione: (2021)
• Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes” by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael Rosenblum
  di: LaVange, Lisa M.
  Pubblicazione: (2021)